Evaluation of Centralised TB Assay Solutions

CompletedOBSERVATIONAL
Enrollment

1,050

Participants

Timeline

Start Date

May 20, 2019

Primary Completion Date

April 17, 2023

Study Completion Date

September 1, 2023

Conditions
TuberculosisDrug-resistant Tuberculosis
Trial Locations (6)

2025

"Institute of Phthisiopneumology Ch. Draganiuc (PPI NRL), Moldova", Chisinau

2193

Division of Wits Health Consortium (DMMH), Johannesburg

23845

Forschungszentrum Borstel. Leibniz Lungenzentrum (Borstel), Borstel

600031

National Institute for Research in Tuberculosis, Chennai

751023

Indian Council of Medical Research (ICMR) Regional Medical Research Centre, Bhubaneswar

Unknown

National Center for Tuberculosis and Lung Diseases, Tbilisi

All Listed Sponsors
lead

Foundation for Innovative New Diagnostics, Switzerland

OTHER

NCT04147676 - Evaluation of Centralised TB Assay Solutions | Biotech Hunter | Biotech Hunter